Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.7K
Overview
85.7K
Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K
Humoral Immune Responses01:36

Humoral Immune Responses

85.3K
Overview
85.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathogenesis of Mayaro Virus-Induced Chronic Arthritis: From Inflammatory Pathways to Targeted Therapeutic Strategies.

Vector borne and zoonotic diseases (Larchmont, N.Y.)·2026
Same author

Particulate matter modulates the transcriptome of peripheral blood mononuclear cells, dysregulates cell metabolism and enhances their carcinogenic activity.

International journal of environmental health research·2026
Same author

Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus.

Oxford open immunology·2026
Same author

Anti-tumor and immunomodulatory activity of Ganoderma parvulum-derived polysaccharides.

Bioscience reports·2025
Same author

Benefits of INSTI-Based Regimens in a Real-World Setting of People Living With HIV-1 in Colombia.

International journal of microbiology·2025
Same author

Percentages of Effector Memory T Cells in Peripheral Blood Associated With Non-Infectious Comorbidities in Common Variable Immunodeficiency Disorders.

Scandinavian journal of immunology·2025

Related Experiment Video

Updated: Mar 13, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K

Cellular Immune Response Induced by mRNA Vaccines Against SARS-CoV-2.

Valentina Tovar1, Isaura Pilar Sánchez2, María Teresa Rugeles1

  • 1Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Immunity, Inflammation and Disease
|March 12, 2026
PubMed
Summary

mRNA vaccines are crucial for controlling COVID-19, inducing robust T-cell responses that offer long-term protection against SARS-CoV-2 variants, even in immunocompromised individuals.

Keywords:
COVID‐19SARS‐CoV‐2cancercellular immunitymRNA vaccinesorgan transplant

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.5K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 13, 2026

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.5K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.9K

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • COVID-19, caused by SARS-CoV-2, has led to millions of deaths globally.
  • Vaccines are the primary strategy for preventing severe COVID-19 illness and mortality.
  • T-cell mediated immunity is vital against SARS-CoV-2 due to its resilience against viral mutations.

Purpose of the Study:

  • To review the T-cell immune responses induced by mRNA vaccines against SARS-CoV-2.
  • To explore the efficacy of these responses in diverse populations, including immunocompromised individuals.

Main Methods:

  • Literature review of studies on mRNA vaccines and SARS-CoV-2 immunity.
  • Analysis of T-cell responses (humoral and cell-mediated) post-vaccination.
  • Examination of vaccine effectiveness in specific patient groups.

Main Results:

  • mRNA vaccines elicit strong T-cell responses crucial for combating SARS-CoV-2.
  • T-cell effector mechanisms are less impacted by viral mutations, ensuring sustained protection.
  • These vaccines demonstrate protective potential across various populations, including those with compromised immune systems.

Conclusions:

  • mRNA vaccines are effective in generating protective T-cell immunity against SARS-CoV-2.
  • The T-cell response is key to long-term protection and combating viral variants.
  • Further research should focus on optimizing vaccine strategies for vulnerable populations.